Skip to content
Revolution Medicines

Executive Director, US Government Affairs

Remote (United States); Remote (United States)Remote · United States
Director+ · Executive
POSTED 19 NOVVERIFIED JUST NOW
Apply Ask
Role
0 days opentrue age
Closes in ~42d at the median (42d)
Posted 19 Nov · n=36
Payats field
$252k–315kposted
▲ +35% vs market median $210k
$165k$315k
Market p25–p75
$165k–$255k
Revolution Medicines p25–p75
$226k–$275kn=125
United States · n=6317 · 365d to 19 Nov
CompanyRevolution Medicines →
337open roles
Opened · 30d
+50
Closed · 30d
−34
13d of snapshots · 30d window
Market
25,433open · Director+ Other
Opened · 7d
+2,3959% of open
All other
621,369open
All tracked boards · live 19 Nov · n=25,433

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

Reporting to the SVP of Global Government and Public Affairs, this leader partners with functional leadership to develop U.S. strategy and directs federal and state policy, advocacy and government engagement. The Executive Director aligns U.S. teams and resources with functional goals, advises senior leaders and resolves complex issues across functions. Decisions have long-term implications for policy outcomes, commercialization readiness and patient access.

Key Responsibilities:

Partner with the U.S. policy team, market access, HEOR, Medical Affairs, and legal to develop U.S. government affairs positions.

Set strategy; establish goals, advocacy plans and measurable outcomes aligned with broader functional strategy, pipeline advancement, commercialization readiness and patient access.

Anticipate federal and state legislative, regulatory and political developments; assess policy scenarios and their implications across business functions, recommend responses and escalate matters requiring enterprise decisions.

Lead proposed U.S. policy positions on pricing, Medicare and Medicaid, coverage and reimbursement, FDA policy, intellectual property, research incentives, diagnostics, data, trade, tariffs and supply chains; coordinate alignment and approval with functional leaders.

Direct coordinated federal and state advocacy plans, prioritizing jurisdictions and issues within agreed resources.

Partner with Global Policy and global government affairs colleagues to maintain consistent positions and address cross-border implications.

Executive counsel and external influence

Partner regularly with the SVP and senior leaders on U.S. policy and advocacy decisions; provide clear recommendations on complex issues, competing priorities and long-term implications grounded in scientific, political and commercial insight.

Represent RevMed in assigned engagements with Congress, the Administration, federal agencies, governors, state legislatures and relevant state agencies; build bipartisan relationships, influence policy and negotiate sensitive matters in alignment with approved company positions.

Prepare executives for high-stakes policy engagements with consistent positions, briefings and messaging.

Cross functional integration and team leadership

Partner with Market Access, Commercial, Clinical Development, Medical Affairs, Regulatory, Manufacturing, Legal, Compliance and Corporate Affairs to integrate U.S. policy insights into coverage and reimbursement strategy, clinical development, launch readiness and enterprise decisions.

Source · Revolution MedicinesFirst seen 19 NovOriginal ↗